CClinicalTrials.gg
Active, not recruitingNCT07304908Updated Dec 26, 2025

Effect of Perception-based Interventions on Public Acceptance of Using Large Language Models in Medicine

An interventional study of Perception-based interventions in Large Language Models, Acceptability of Health Care and Perception, Self, sponsored by Peking University. Active, not recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-26.

Sponsored by Peking University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
3,000
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Large language models (LLMs) show promise in medicine, but concerns about their accuracy, coherence, transparency, and ethics remain. To date, public perceptions on using LLMs in medicine and whether they play a role in the acceptability of health care applications of LLMs are not yet fully understood. This study aims to investigate public perceptions on using LLMs in medicine and if interventions for perceptions affect the acceptability of health care applications of LLMs.

Read the detailed description

Owing to rapid advances in artificial intelligence, large language models (LLMs) are increasingly being used in a variety of clinical settings such as triage, disease diagnosis, treatment planning, and self-monitoring. Despite their potential, the use of LLMs remains restricted within healthcare settings due to lack of accuracy, coherence, and transparency and ethical concerns. Public perceptions such as perceived usefulness and risks play a crucial role in shaping their attitudes towards artificial intelligence that can either facilitate or hinder its adoption. Yet, to our knowledge, there is lack of awareness about perception-driven interventions in health care and no previous studies have examined whether public perceptions play a role in the acceptability of medical applications of LLMs. Hence, this study aims to investigate public perceptions on using LLMs in medicine and if interventions for perceptions affect the acceptability of health care applications of LLMs.

02

Conditions studied

  • Large Language Models
  • Acceptability of Health Care
  • Perception, Self

Keywords

  • Large language model
  • Artificial intelligence
  • Perception-based interventions
  • Public acceptance
03

In context

Patient Acceptance of Health Care

93 studies on the registry are indexed under Patient Acceptance of Health Care; 30 are open to participants now.

This study's planned enrollment of 3,000 is above the median of 238 across 74 interventional studies indexed under Patient Acceptance of Health Care.

Browse Patient Acceptance of Health Care studies →

Lead sponsor

Peking University is the lead sponsor of 411 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • ≥18 years
  • Capable of completing an online survey
  • Agree to sign an informed consent form

Exclusion criteria

Exclusion Criteria:

  • Unable to answer questions or communicate
  • Not willing to participate in this study
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
3,000 participants (estimated)

Study arms

  • Experimental
    Perceived benefits of large language models in medicine

    Participants were asked to read "In April 2023, Massachusetts General Hospital launched a pilot program utilizing medical LLMs to assist with emergency department triage and initial diagnosis and observed a reduction in patient wait times and an improvement in clinical efficiency."

    Other: Perception-based interventions

  • Experimental
    Perceived racial bias in large language models in medicine

    Participants were asked to read "In November 2022, a research team from the University of California, San Francisco found that cutting-edge medical LLMs exhibited racial bias when recommending treatment plans."

    Other: Perception-based interventions

  • Experimental
    Perceived ethical conflicts in large language models in medicine

    Participants were required to read "In February 2023, a major European hospital network inadvertently leaked partially anonymized but still sensitive patient data during the testing of medical LLMs due to a system configuration error. Although no direct patient harm occurred, this increased public concerns regarding data privacy and security and compelled relevant institutions to conduct urgent reviews of their data protection measures."

    Other: Perception-based interventions

  • No intervention
    Control

    No intervention

Interventions

  • OtherPerception-based interventions

    Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.

06

What researchers measure

Primary outcomes

  1. Number of participants who will change their attitudes towards medical applications of large language models

    Public acceptance of applying large language models to medicine will be categorized into yes, not sure, and no, which will be collected before perception-based interventions and after interventions.

    Time frame: Through study completion, an average of 1 year

07

Study locations

1 site
  • Jue Liu
    Beijing, Beijing Municipality 100191, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07304908
Lead sponsor
Peking University
Collaborators
Peking University Third Hospital
Responsible party
Liu Jue (Prof., Peking University) — Principal investigator
First posted
Dec 26, 2025
Start date
Nov 25, 2025
Primary completion
Oct 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Dec 26, 2025

Study contacts

Jue Liu
principal investigator · Peking University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion